Ensurge Micropower - Termination of trading on OTC QB Venture

23 Jan 2026 15:01 CET

Ensurge Micropower ASA (OSE: ENSU) has decided to terminate trading of its
securities on the US OTC market, effective March 11, 2026. The Company's shares
will remain listed on the Oslo Stock Exchange.

The termination of trading applies to the Company's American Depositary Receipts
(ADRs) and F Shares on the OTCQB Venture Market.

The decision follows a strategic review of the Company's securities trading
structure and is part of management's efforts to streamline operations and
optimize the use of the Company's resources. Trading volume on the OTC market
has been minimal since the admission to trading, while the associated costs –
including Directors and Officers insurance, compliance, and reporting
requirements – are substantial enough that maintaining trading on OTCQB is not
cost-effective or profitable.

– This is a natural decision that stems from our disciplined focus to eliminate
unnecessary costs and focus our resources where they create the most value, says
Shauna McIntyre, CEO of Ensurge Micropower.

– Our primary listing on the Oslo Stock Exchange provides strong liquidity and
access to our core investor base. We remain committed to transparent
communication with all shareholders as we execute our strategic plan.

This is the first of several measures being implemented under new leadership to
strengthen Ensurge's financial position and operational focus. The Company will
provide further updates on cost optimization initiatives in the coming weeks.

For further information, please contact: ir@ensurge.com

About Ensurge Micropower: Ensurge (www.ensurge.com) powers the future of
AI-enabled devices with advanced microbattery technology that delivers unmatched
performance and safety. From its base in San Jose, California, the Company's
team of battery specialists have pioneered thin-film batteries produced on
high-precision roll-to-roll production processes. These innovations enable new
possibilities in form-factor-constrained applications across consumer, medical,
and industrial markets. Ensurge partners with leading global customers to
accelerate their products to market and is listed on the Oslo Stock Exchange.
For more news and information on Ensurge, please visit
https://www.ensurge.com/news-room.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site